Company: CERO
Filing Date: 2025-01-14
Form Type: 424B3
Source: 0001213900-25-003436
Chunk: 5

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-14
Form: 424B3
Chunk 5
---
 which was the closing price of the Common Stock on Nasdaq on January 3, 2025,
to such holder as a condition to the Warrant Exercises thereby. Such shares were issued in reliance upon the exemption from registration
set forth in Section 4(a)(2) of the Securities Act of 1933, as amended.

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

| Date: January 10, 2025 | CERO THERAPEUTICS HOLDINGS, INC. |                         |
|:-----------------------|:---------------------------------|:------------------------|
|                        | By:                              | /s/ Chris Ehrlich       |
|                        | Name:                            | Chris Ehrlich           |
|                        | Title:                           | Chief Executive Officer |

<div align='center'>2</div>